GlaxoSmithKline Vaccines Srl
FDA inspection history in Sovicille, Italy, 2024
- 1
- Form 483
Every document, by year
- Form 483
2024: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2024One Form 483, at Sovicille, Italy.
Cited most
Across all GlaxoSmithKline Vaccines Srl observations on file
- 21 CFR 211.160(a)General requirements1
- 21 CFR 211.192Production record review1
- 21 CFR 211.22(d)Responsibilities of quality control unit1
- 21 CFR 211.25(a)Personnel qualifications1
- 21 CFR 314.80(c)(1)(i)Postmarketing reporting of adverse drug experiences1
The complete GlaxoSmithKline Vaccines Srl file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Sovicille, Italy
One Form 483 · 2024 · 5 observations
Latest: Form 483, Jan 26, 2024 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2024-01-26 | 483 Form 483 | Sovicille, Italy | 5 | $99 |
Investigators on these documents
FEI number 3006738517 · most recent document Jan 26, 2024
About GlaxoSmithKline Vaccines Srl
How many FDA Form 483s has GlaxoSmithKline Vaccines Srl received?
FDA Intel has 1 Form 483 on file for GlaxoSmithKline Vaccines Srl; the most recent is dated Jan 26, 2024.
When was GlaxoSmithKline Vaccines Srl last inspected by FDA?
The most recent FDA inspection document on file for GlaxoSmithKline Vaccines Srl is a Form 483 dated Jan 26, 2024, for the site in Sovicille, Italy.
What did FDA cite at GlaxoSmithKline Vaccines Srl?
The regulations cited most in the observations on file for GlaxoSmithKline Vaccines Srl are 21 CFR 211.160(a) (General requirements), 1 time; 21 CFR 211.192 (Production record review), 1 time; 21 CFR 211.22(d) (Responsibilities of quality control unit), 1 time.